Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
DZ: Conceptualization, Writing review & editing
BPC-157 beginning to accumulate
For a broader overview of fragment peptides and how they fit into modern research programs, see our complete guide to peptides
Glutamine, Glycine, Cysteine Reduces oxidative stress in cells Supports liver detoxification Improves skin clarity and reduces discoloration Enhances insulin sensitivity and aids in weight loss Offers anti-inflammatory and antioxidant benefits Helps manage autoimmune disease symptoms Supports brain health, anti-aging, and DNA repair